Search results
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo Finance· 4 days agoAbbVie is graded C on this front, indicating that it is trading at par with its peers. Click here to...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 5 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) had its target price cut by equities researchers at Barclays from $195.00 to $187.00 in a research report issued on Monday, Benzinga reports ...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number ...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 3 days agoApart from strategic acquisitions, BMS advanced the clinical development of a number of its own pipeline drugs, such as the potential first-in-class...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KLAS Las Vegas· 4 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
Coming to a CVS Near You: A Store Brand Monoclonal Antibody
The Wall Street Journal· 6 days agoBut this year the strategy changed. In...1 and replace it with biosimilars. There is a catch,...
Trials to watch: Four ALS drugs to keep an eye on
Clinical Trials Arena via Yahoo Finance· 4 days agoGlobalData is the parent company of the Clinical Trials Arena. HEALEY Platform trial investigates Calico and AbbVie drug The HEALEY ALS Platform Trial...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 3 days agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
